V1.3c On a monthly basis, detect PLWHA with persistently high viremia [high VL loads over two consecutive quarterly measurements] and notify OMC and MCM providers to enable targeted response. Monitor improvement in VL levels to ensure efficacy of provider response. The monthly monitoring has Part A/MAI begun, although the number of PLWHA who may be identified as having historically high viremia is limited to those whose VL measurements were in place before the current 100% VL measurement enforcement began in March, 2017. Data will be available in July. V1.3d Beginning January 1, 2018 (Second Year), identify at least one (1) Viral Load (non)Suppression Part A/MAI Quality Improvement opportunity per year (identify, pilot-test, evaluate, implement improvement). NHAS GOAL #3: REDUCE HIV-RELATED HEALTH DISPARITIES AND HEALTH INEQUITIES (2017 IMPLEMENTATION) DISPARITIES IN TREATMENT OUTCOMES (SUPPRESSED / UNDETECTABLE VL LEVELS) Responsible 2017 July Oct Jan Objective Strategies Activities/Measurements Entities goal 2017 2017 2017 2018 DV1. By 2021, PROGRESS TOWARD OBJECTIVES: a. a. a. a. a. a. Black/African American Males: from 57% suppressed VL in 2015 to 80%. 60% b. b. b. b. increase the b. Black/African American Females: from 60% suppressed VL in 2015 to RWP Part A b. c. c. c. c. percentage of 80%. QM 64% clients in RWP care c. Haitians: from 68% suppressed VL in 2015 to 80%. c. among three (3) key 72%
V1.3c On a monthly basis, detect PLWHA with persistently high viremia [high VL loads over two consecutive quarterly measurements] and notify OMC and MCM providers to enable targeted response. Monitor improvement in VL levels to ensure efficacy of provider response. The monthly monitoring has begun, although the number of PLWHA who may be identified as having historically high viremia is limited to those whose VL measurements were in place before the current 100% VL measurement enforcement began in March, 2017. Data will be available in July. Part A/MAI V1.3d Beginning January 1, 2018 (Second Year), identify at least one (1) Viral Load (non)Suppression Quality Improvement opportunity per year (identify, pilot-test, evaluate, implement improvement). Part A/MAI NHAS GOAL #3: REDUCE HIV-RELATED HEALTH DISPARITIES AND HEALTH INEQUITIES (2017 IMPLEMENTATION) DISPARITIES IN TREATMENT OUTCOMES (SUPPRESSED / UNDETECTABLE VL LEVELS) Objective Strategies Activities/Measurements Responsible Entities 2017 goal 2017 July 2017 Oct 2017 Jan 2018 DV1. By 2021, increase the percentage of clients in RWP care among three (3) key PROGRESS TOWARD OBJECTIVES: a. Black/African American Males: from 57% suppressed VL in 2015 to 80%. b. Black/African American Females: from 60% suppressed VL in 2015 to 80%. c. Haitians: from 68% suppressed VL in 2015 to 80%. RWP Part A QM a. 60% b. 64% c. 72% a. b. c. a. b. c. a. b. c. a. b. c.
Miami_EMA_IP_PROGRESS_-_CY_2017_4-10-17.docx